or Try an Advanced Search...

    Stage Pharmaceutical Stocks List

    Symbol Grade Name % Change
    PSTV F Plus Therapeutics, Inc. 0.00
    KALV F KalVista Pharmaceuticals, Inc. 0.00
    SVRA F Savara, Inc. 0.00
    CNSP D CNS Pharmaceuticals, Inc. 0.00
    KPTI D Karyopharm Therapeutics Inc. 0.00
    RVPH D Reviva Pharmaceuticals Holdings, Inc. 0.00
    CASI D CASI Pharmaceuticals, Inc. 0.00
    HRMY D Harmony Biosciences Holdings, Inc. 0.00
    MBRX C Moleculin Biotech, Inc. 0.00
    IKT C Inhibikase Therapeutics, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pharmaceutical Cancer Disease Medicine Chemotherapy Chloroarenes Clinical Medicine Neurological Disorders Oncology Psychiatric Diagnosis Treatment Of Cancer Acromegaly Acute Myeloid Leukemia Advanced Solid Tumors Aging Associated Diseases Antibody Drug Conjugate Antineoplastic Drugs Autoimmune Disease Biotechnology Bipolar Disorder

    Related ETFs - A few ETFs which own one or more of the above listed Stage Pharmaceutical stocks.

    Symbol Grade Name Weight
    BBP C BioShares Biotechnology Products Fund 1.67
    CNCR F Loncar Cancer Immunotherapy ETF 1.57
    JSML B Janus Small Cap Growth Alpha ETF 1.33
    XPH B SPDR S&P Pharmaceuticals ETF 1.22
    GRPZ B Invesco Exchange-Traded Fund Trust II Invesco S&P SmallCap 600 GARP ETF 0.97
    View all Stage Pharmaceutical ETFs...
    Compare ETFs
    Compare BBP to JSML Compare CNCR to XPH Compare JSML to XPH

        Stage Pharmaceutical Stocks Recent News

        Date Stock Title
        Nov 21 HRMY HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
        Nov 20 KPTI Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer
        Nov 19 RVPH RVPH: Year-End OLE Update
        Nov 18 IKT Inhibikase Therapeutics files for secondary offering of common stock
        Nov 18 CNSP CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
        Nov 18 KPTI Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition
        Nov 17 PSTV Plus Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 17 CASI CASI Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
        Nov 16 PSTV Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript
        Nov 15 RVPH Reviva Pharmaceuticals reports Q3 results
        Nov 15 CNSP CNS Pharmaceuticals reports Q3 results
        Nov 15 CNSP CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Pharmaceutical Cancer Disease Medicine Chemotherapy Chloroarenes Clinical Medicine Neurological Disorders Oncology Psychiatric Diagnosis Treatment Of Cancer Acromegaly Acute Myeloid Leukemia Advanced Solid Tumors Aging Associated Diseases Antibody Drug Conjugate Antineoplastic Drugs Autoimmune Disease Biotechnology Bipolar Disorder
        Stage Pharmaceutical

        Stage Pharmaceutical is a biopharmaceutical company focused on developing innovative treatments for rare and neglected diseases. The company is developing a portfolio of novel therapies for rare and neglected diseases, including rare genetic disorders, rare cancers, and rare infectious diseases. Stage Pharmaceutical is committed to developing treatments that are safe, effective, and affordable for patients.

        Browse All Tags